Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Ascletis Pharma Inc
2VJCurrent price
0.096 EUR
-0.001 EUR (-1.03%)
Last closed
0.11 EUR
Company
www.ascletis.com
ISIN
KYG0520K1094
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
111 256 216 EUR
Yield for 12 month
-56.36 %
1Y
3Y
5Y
10Y
15Y
2VJ
Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China. The company offers Ritonavir tablet; and ASCLEVIR and GANOVO for the treatment of Hepatitis C virus. It is also developing ASC22 for treating CHB and HIV functional cure; ASC10 for respiratory syncytia virus; ASC10 and ASC11 to treat COVID-19; ASC40, ASC41, ASC42, ASC43F FDC for non-alcoholic steatohepatitis; and ASC42 for the treatment of primary biliary cholangitis. In addition, the company is developing ASC40 to treat recurrent glioblastoma; ASC61 for advanced solid tumors; and ASC40, an oral small molecule for the treatment of acne. Ascletis Pharma Inc. was founded in 2013 and is headquartered in Hangzhou, the People's Republic of China. Address: Building D, Hangzhou, China, 311200
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
–P/E ratio
–Dividend Yield
–Current Year
+56 161 886 EUR
Last Year
+53 675 108 EUR
Current Quarter
–
Last Quarter
–
Current Year
+25 790 647 EUR
Last Year
-24 502 603 EUR
Current Quarter
–
Last Quarter
–
Key Figures 2VJ
1 year
3 years
5 years
10 years
EBITDA
-384 590 246 EUR
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-10.18 %
PEG Ratio
–
Return On Equity TTM
-10.89 %
Wall Street Target Price
–
Revenue TTM
10 012 606 EUR
Book Value
2.13 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-36.4 %
Dividend Yield
–
Gross Profit TTM
-24 502 603 EUR
Earnings per share
-0.03 EUR
Diluted Eps TTM
-0.03 EUR
Most Recent Quarter
II 2023
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics 2VJ
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 2VJ
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation 2VJ
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
0.2318
Price Sales TTM
11.1116
Enterprise Value EBITDA
-0.1245
Price Book MRQ
0.357
Financials 2VJ
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 2VJ
For 52 weeks
0.083 EUR
0.25 EUR
50 Day MA
0.1 EUR
Shares Short Prior Month
–
200 Day MA
0.14 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart